Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
07/2012
07/26/2012US20120190725 Inhibitor(s) of transporters or uptake of monoaminergic neurotransmitters
07/26/2012US20120190724 Novel anticancer-aiding compound, method for preparing the same, anticancer-aiding composition containing the same and method for reducing anticancer drug resistance using the same
07/26/2012US20120190723 Viral modulators and processes thereof
07/26/2012US20120190722 Ketorolac tromethamine compositions for treating or preventing ocular pain
07/26/2012US20120190721 Method for treating nervous system disorders and conditions
07/26/2012US20120190720 Combination Therapy With Parp Inhibitors
07/26/2012US20120190719 Methods of treating motor disorders with alpha-2b andrenergic receptor agonists
07/26/2012US20120190718 Diarylthiohydantoin compounds
07/26/2012US20120190717 Methods and compositions for increasing the anaerobic working capacity in tissues
07/26/2012US20120190716 Methods and uses of cytochrome p450 inhibitors
07/26/2012US20120190715 Highly penetrating compositions and methods for treating pathogen-induced disordered tissues
07/26/2012US20120190714 Alpha ketoamide compounds as cysteine protease inhibitors
07/26/2012US20120190713 Antimicrobial ortho-fluorophenyl oxazolidinones for treatment of bacterial infections
07/26/2012US20120190712 Methods for Treating Cognitive Disorders
07/26/2012US20120190711 Lenalidomide salts
07/26/2012US20120190710 Bicyclo-heptan-2-amines
07/26/2012US20120190709 Indazolyl-substituted dihydroisoxa-zolopyridines and methods of use thereof
07/26/2012US20120190708 Targeting nad biosynthesis in bacterial pathogens
07/26/2012US20120190707 Selective inhibitors of akt and methods of using same
07/26/2012US20120190706 Acetamide and carboxamide derivatives of azaadamantane and methods of use thereof
07/26/2012US20120190705 Methods of inhibiting choroidal neovascularization
07/26/2012US20120190704 Azaadamantane ester and carbamate derivatives and methods of use thereof
07/26/2012US20120190703 Salts of 13a-(s)desoxytylophorinine, preparation methods and pharmaceutical compositions and uses thereof
07/26/2012US20120190702 Use of methylnaltrexone and related compounds to treat constipation in chronic opioid users
07/26/2012US20120190701 Renin inhibitors
07/26/2012US20120190700 Novel 4-amino-n-hydroxy-benzamides for the treatment of cancer
07/26/2012US20120190699 Pyridones useful as inhibitors of kinases
07/26/2012US20120190698 Methods of predicting thiopurine response
07/26/2012US20120190697 Hiv inhibiting bicyclic pyrimidine derivatives
07/26/2012US20120190696 Inhibitors of fatty acid binding protein (fabp)
07/26/2012US20120190695 Phenyloxadiazole derivatives as pgds inhibitors
07/26/2012US20120190694 Selective sphingosine-1-phosphate receptor antagonists
07/26/2012US20120190693 Reverse Amide Compounds As Protein Deacetylase Inhibitors And Methods Of Use Thereof
07/26/2012US20120190692 Selective substituted pyridine ligands for neuronal nicotinic receptors
07/26/2012US20120190691 Pharmaceutical compositions for treatment of respiratory and inflammatory diseases
07/26/2012US20120190690 Eltoprazine for the treatment of weight disorders
07/26/2012US20120190689 Piperazinyl 3-aminopyrrolidine derivatives as a ccr2 antagonist
07/26/2012US20120190688 Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
07/26/2012US20120190686 Bicyclo[3.2.1]octyl amide derivatives and uses of same
07/26/2012US20120190685 Novel phenylimidazole derivative as pde10a enzyme inhibitor
07/26/2012US20120190682 Modulators for amyloid beta
07/26/2012US20120190681 Picolinamide inhibitors of kinases
07/26/2012US20120190680 Heteroaryl Amide Analogues
07/26/2012US20120190679 Novel Protein Kinase B Inhibitors - 060
07/26/2012US20120190678 Substituted pyrazolo-quinazoline derivatives as kinase inhibitors
07/26/2012US20120190677 Novel tetrahydroquinoline derivatives
07/26/2012US20120190676 Inhibitors of mtor kinase as anti-viral agents
07/26/2012US20120190675 Azaspirohexanones
07/26/2012US20120190674 Sulfonamides as trpm8 modulators
07/26/2012US20120190673 Pyrazole compounds that modulate the activity of cdk, gsk and aurora kinases
07/26/2012US20120190672 Fused aminodihydrothiazine derivatives
07/26/2012US20120190671 Controlled-Release CNS Modulating Compositions and Methods for the Treatment of Otic Disorders
07/26/2012US20120190670 Transnasal Anticonvulsive Pharmaceutical Composition Comprising Poorly Soluble Anticonvulsant
07/26/2012US20120190669 Oxindole compounds
07/26/2012US20120190668 Enhancement of cellular transplantation using small moleucle modulators of hepatocyte growth factor (scatter factor) activity
07/26/2012US20120190667 Method of making solid dispersions of highly crystalline therapeutic compounds
07/26/2012US20120190666 Heteroaryl Compounds as PIKK Inhibitors
07/26/2012US20120190665 Pyrazolopyrimidine jak inhibitor compounds and methods
07/26/2012US20120190664 Process for the preparation of antibiotic compounds
07/26/2012US20120190663 Use of free dna as an early predictor of severity in acute pancreatitis
07/26/2012US20120190662 Pharmaceutical propylene glycol solvate compositions
07/26/2012US20120190661 Androgen composition for treating an opthalmic condition
07/26/2012US20120190660 17-hydroxy-17-pentafluoroethyl-estra-4,9(10)-diene-11-ethynylphenyl derivatives, methods for the production thereof and use thereof for treating diseases
07/26/2012US20120190659 Angiogenesis inhibitors
07/26/2012US20120190658 Method And Composition For The Treatment Of Adverse Skin Conditions
07/26/2012US20120190657 Biphenyl compounds useful as muscarinic receptor antagonists
07/26/2012US20120190656 Methods for selecting therapies to improve hdl cholesterol and triglyceride levels
07/26/2012US20120190655 Intravenous Formulation with Water-Soluble CoCrystals of Acetylsalicylic Acid and Theanine
07/26/2012US20120190654 Novel bicyclic urea compounds
07/26/2012US20120190653 Therapeutic eye drop comprising doxycycline and a stabilizer
07/26/2012US20120190652 Diagnostic agent for parkinson's disease
07/26/2012US20120190651 Anti-inflammatory compounds
07/26/2012US20120190650 Inhibitors of Autotaxin
07/26/2012US20120190649 Bicyclic aryl sphingosine 1-phosphate analogs
07/26/2012US20120190648 Fluorinated cyclopropane analogs of glutamic acid
07/26/2012US20120190647 Novel oral forms of a phosphonic acid derivative
07/26/2012US20120190646 Compositions Comprising Thalidomide and Artemisinin for the Treatment of Cancer
07/26/2012US20120190645 Organic compounds
07/26/2012US20120190644 Viscoelastic gels as novel fillers
07/26/2012US20120190643 Carbohydrate composition for flat glucose response
07/26/2012US20120190642 Isoflavones for treating mucopolysaccharidoses
07/26/2012US20120190641 Use of Non-Digestible Oligosaccharides
07/26/2012US20120190640 Cyanocobalamin low viscosity aqueous formulations for intranasal delivery
07/26/2012US20120190639 Treatment or prophylaxis of proliferative conditions
07/26/2012US20120190638 Methods of treating hematologic cancers
07/26/2012US20120190637 Combination therapy treatment for viral infections
07/26/2012US20120190636 Composition for prophylaxis or treatment of urinary system infection and method thereof
07/26/2012US20120190635 Selective oxidation of c-h bonds of modified substrates by p450 monooxygenase
07/26/2012US20120190634 Lipoteichoic acid-derived glycolipids, and compositions comprising same
07/26/2012US20120190633 Monophosphorylated lipid a derivatives
07/26/2012US20120190632 Anti-bacterial infection, inflammation, and leukemia composition and use thereof
07/26/2012US20120190631 Materials and methods relating to glycosylation
07/26/2012US20120190628 Genes and polypeptides relating to human colon cancers
07/26/2012US20120190627 Cosmetic use of lacritin-type polypeptides
07/26/2012US20120190623 Inactivation Resistant Factor VIII
07/26/2012US20120190620 Methods to identify targets and molecules regulating purinosomes and their uses
07/26/2012US20120190618 Method and pharmaceutical compositions for trans-buccal mucosa treatment of postprandial hyperglycaemia in type ii diabetes
07/26/2012US20120190617 Niacin and/or trigonelline as a muscle stimulant
07/26/2012US20120190612 Methods of treatment
07/26/2012US20120190543 Pesticidal compositions
1 ... 1110 1111 1112 1113 1114 1115 1116 1117 1118 1119 1120 1121 1122 1123 1124 1125 1126 1127 1128 1129 1130 ... 7860